DQD-26749-91241
2 vaccinations
4 coded responses
24 check-ins
4 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 800 / CO
- Registered
- 2021-02-13
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-13
Registered in v-safe
-
2021-02-13
Dose 1 — Pfizer-BioNTech
- 2021-02-13
- 2021-02-14
- 2021-02-15
- 2021-02-16
- 2021-02-17
- 2021-02-19
- 2021-02-20
- 2021-02-27
-
2021-03-06
Dose 2 — Pfizer-BioNTech
- 2021-03-06
-
2021-03-07
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-03-08
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Joint pains, NauseaAdult check-in
-
2021-03-09
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Headache, Joint painsAdult check-in
-
2021-03-10
Health check-in — days 1–6 daily, dose 2Feeling: Good · Joint pains, Fatigue or tirednessAdult check-in
- 2021-03-11
- 2021-03-12
- 2021-03-13
- 2021-03-20
- 2021-03-27
-
2021-04-03
Survey response — day 28, dose 2MedDRA: Headache — Feeling: GoodFree text: Recurring headaches. 3 days this week.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-10
Survey response — day 35, dose 2MedDRA: Urticaria — Feeling: GoodFree text: Hives for 4 days and still present. May be food related. I had spaghetti squash. I have not had such a strong reaction before.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-17
Survey response — day 42, dose 2MedDRA: Arthralgia, Fatigue, Headache, Myalgia, Nausea, Vomiting — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Fatigue, vomitting, nausea, headache, muscle ache, joint painMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-17
Report sent to call center — day 42, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-06-06
- 2021-09-04
-
2022-03-08
Survey response — 12 months, dose 2MedDRA: COVID-19, Eye disorder, Fatigue, Hypersensitivity, Migraine, Nasal congestion, Pre-existing disease, Pyrexia, Respiratory tract congestion — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: I had COVID in November 2021 Fever for 4 days, then congestion started and nose blocked about 3 days. Fatigue lasted an additional 5 days. So in total about 12 days Allergies harsher this year affecting my eyes Hormonal migraines more severe&frequentMedDRA releases: 2024-11 · check-in free text available
- 2022-04-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-13 | Pfizer-BioNTech | |
| 2 | 2021-03-06 | Pfizer-BioNTech |
Call center
1 call center case
1 unsuccessful
1 wait over 3 months for a first call
Free text
Release 6 — day 28, dose 2
Symptoms: Recurring headaches. 3 days this week.
Release 7 — day 35, dose 2
Symptoms: Hives for 4 days and still present. May be food related. I had spaghetti squash. I have not had such a strong reaction before.
Release 7 — day 42, dose 2
Symptoms: Fatigue, vomitting, nausea, headache, muscle ache, joint pain
Release 11 — 12 months, dose 2
Symptoms: I had COVID in November 2021 Fever for 4 days, then congestion started and nose blocked about 3 days. Fatigue lasted an additional 5 days. So in total about 12 days Allergies harsher this year affecting my eyes Hormonal migraines more severe&frequent cut off by CDC
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Arthralgia | ✓ | ✓ | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Eye disorder | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | ✓ | ✓ | ✓ |
| SD | Hypersensitivity | · | · | ✓ |
| SD | Migraine | · | · | ✓ |
| SD | Myalgia | ✓ | ✓ | ✓ |
| SD | Nasal congestion | · | · | ✓ |
| SD | Nausea | ✓ | ✓ | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Urticaria | ✓ | ✓ | ✓ |
| SD | Vomiting | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release